Continuous Monitoring of Patients in and After the Acute Admission Ward to Optimize Clinical Pathways
NCT: NCT05181111 · COMPLETED
Brief Summary
Hospitals aim to hospitalize patients when necessary and discharge patients when possible. However, the triage process and discharge management of patients in e.g. the Acute Admission Ward, is not a trivial task. The upcoming technology of wearable monitoring devices, whereby patients can be continuously monitored with an unobtrusive vital signs device, might help getting more insight into patients' health condition and thus help facilitate efficient and effective triaging. Therefore, the primary objective is to assess the effects of continuous monitoring of patients in the acute admission ward (AAW) on the percentage of patients who can be discharged home. Secondary objectives are to assess the length of stay in the acute admission ward and in the in-hospital wards, as well as the effect on admission to the intensive care unit, rapid response team calls and hospital readmission. The predictive value of algorithms applied to the monitoring data combined with other parameters to detect timely deterioration and predict discharge will be assessed. Facilitators and barriers for implementing such a system will be investigated.
Frequently Asked Questions
What is Continuous Monitoring of Patients in and After the Acute Admission Ward to Optimize Clinical Pathways?
Continuous Monitoring of Patients in and After the Acute Admission Ward to Optimize Clinical Pathways is a clinical trial registered under NCT05181111. Current status: COMPLETED.
What is the status of NCT05181111?
The current status of NCT05181111 (Continuous Monitoring of Patients in and After the Acute Admission Ward to Optimize Clinical Pathways) is: COMPLETED.
When did Continuous Monitoring of Patients in and After the Acute Admission Ward to Optimize Clinical Pathways start?
Continuous Monitoring of Patients in and After the Acute Admission Ward to Optimize Clinical Pathways started on 2021-12-06.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.